CDX
SK-UT-1
Tumor indication
Uterine
Tumor subtype
Uterine Leiomyosarcoma
Description
SK-UT-1 (Uterine Cancer CDX Model)
The SK-UT-1 line was derived from a uterine leiomyosarcoma. It represents a rare and aggressive form of uterine cancer. SK-UT-1 has been applied in preclinical sarcoma and gynecologic oncology research. Its reproducibility supports translational rare tumor studies.
Key Features:
- Derived from uterine leiomyosarcoma.
- Aggressive sarcoma phenotype.
- Tumorigenic in xenografts.
- Rare tumor biology.
Applications:
SK-UT-1 is used in rare tumor drug discovery, particularly in leiomyosarcoma. Researchers apply it in biomarker development and targeted therapy studies. It supports translational pipelines for gynecologic oncology. Its rarity makes it valuable for focused drug testing.
Details
- Tumor indication
- Uterine
- Tumor subtype
- Uterine Leiomyosarcoma
- Organism
- Human
- Mouse sex
- Female
- Lumin data
- Proteomics, RNA-Seq, WES
Mutated genes
Select a gene to see the variants recorded for this line.
Gene expression
Show all values
| Gene | Expression |
|---|
Expression measured across the Champions panel.
Lumin data
Request this cell line
Let's build the right study, together.
Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.